The retail price of brand-name GLP-1 medications can exceed $1,000 per month. For patients without insurance coverage — or whose insurance specifically excludes weight loss drugs — that number feels like a locked door. But it doesn’t have to be. Multiple pathways exist to access effective weight loss medication at a fraction of the brand-name cost. Here’s a clear-eyed breakdown of your options.
Why Brand-Name GLP-1 Medications Are So Expensive
Wegovy (semaglutide for weight loss) carries a list price of approximately $1,349 per month. Zepbound (tirzepatide) is similar. These prices reflect pharmaceutical company pricing strategies, patent protections, and the high cost of clinical development. They do not reflect the actual cost of producing the medication.
Insurance coverage for weight loss medication is inconsistent. Many plans specifically exclude anti-obesity medications, and even those that cover them often impose prior authorization requirements, step therapy protocols, or high copays. Medicare Part D currently does not cover weight loss medications, though legislation to change this is under consideration.
The result: millions of people who qualify for GLP-1 treatment can’t access it through traditional channels. But traditional channels aren’t the only option.
Compounded Semaglutide: The Most Accessible Option
Compounding pharmacies can legally produce semaglutide formulations when the brand-name version is in shortage or unavailable. These compounded versions use the same active ingredient — semaglutide — prepared by licensed pharmacists in FDA-registered facilities.
Costs for compounded semaglutide typically range from $150-$400 per month, depending on the provider and dosage. That’s 70-85% less than the brand-name alternative.
What to look for in a compounding pharmacy:
- FDA-registered and state-licensed
- 503A or 503B designation (503B outsourcing facilities face stricter FDA oversight)
- Third-party tested for purity and potency
- Transparent about ingredients and sourcing
Harbor Healthcare works with vetted compounding pharmacies that meet these standards, ensuring you receive safe, effective medication at an accessible price.
Telehealth Programs: Cutting the Overhead
Traditional healthcare adds cost at every step: office visit copays, lab orders, specialist referrals, time off work. Telehealth weight loss programs eliminate most of this overhead. You consult with a licensed provider from home, receive a prescription electronically, and have medication shipped to your door.
Harbor Healthcare’s pricing includes provider consultations, prescription management, and ongoing support — no hidden fees, no surprise charges. Our goal is to make the total cost of treatment predictable and affordable.
Using HSA and FSA Funds
If you have a Health Savings Account (HSA) or Flexible Spending Account (FSA), weight loss medication prescribed by a licensed provider is typically an eligible expense. This means you can pay for your GLP-1 treatment with pre-tax dollars, effectively reducing the cost by 20-35% depending on your tax bracket.
Key details:
- You need a prescription from a licensed healthcare provider (which Harbor Healthcare provides)
- A Letter of Medical Necessity (LMN) may be required — your provider can supply this
- Both the medication and the provider consultation fees are typically covered
- FSA funds expire at year-end (with some exceptions), so plan accordingly
Manufacturer Savings Programs
Novo Nordisk (maker of Wegovy) and Eli Lilly (maker of Zepbound) both offer savings cards and patient assistance programs. However, these programs have significant limitations:
- Most require commercial insurance coverage as a prerequisite
- Savings cards typically reduce copays, not the full price
- Patient assistance programs for uninsured patients exist but have income thresholds and lengthy application processes
- Programs can change or expire without notice
These are worth exploring but aren’t reliable as a primary strategy for most patients paying out of pocket.
The Real Cost Calculation: Medication vs. Obesity
Before dismissing weight loss medication as too expensive, consider the cost of not treating obesity. The CDC estimates that the annual medical cost for an adult with obesity is approximately $1,861 higher than for someone at a healthy weight. That doesn’t include indirect costs like reduced productivity, missed work, and quality of life.
For patients with obesity-related conditions like type 2 diabetes, the numbers are even starker. The average annual cost of diabetes management is over $9,600 per person. Many patients who achieve significant weight loss on GLP-1 medications reduce or eliminate their need for diabetes, blood pressure, and cholesterol medications — producing real savings that offset the cost of treatment.
What Harbor Healthcare Costs
We believe in transparent pricing. Harbor Healthcare’s program is designed for patients who are paying out of pocket, whether by choice or necessity. Our pricing covers:
- Licensed provider consultations via telehealth
- Prescription and medication management
- Ongoing follow-up and dose adjustments
- Compounded semaglutide shipped directly to you
No insurance required. No hidden fees. No contracts.
The Bottom Line
The sticker price of brand-name GLP-1 medications is not the price you have to pay. Between compounded formulations, telehealth efficiency, HSA/FSA eligibility, and transparent pricing programs like Harbor Healthcare, effective weight loss medication is accessible at a fraction of the retail cost. Don’t let the price tag of Wegovy or Zepbound convince you that treatment is out of reach.
Take our free assessment to get started. We’ll walk you through exactly what treatment costs and whether it’s the right fit for your budget and your health.